Adam Ang
Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images.
The web service estimates a user's psychological age and creates a personalised mental health programme.
This follows last year's FDA approvals in the US.
It will use the funds to deepen its presence across Asia.
The company has also launched a distribution unit in the United States.
The company plans to bring its technology to 10,000 more doctors in the country.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.
The secondary care platform will soon offer online doctor consultations as part of its expansion into primary care.
They will provide the first access to an AI-enabled minimal residual disease test in India.
Two variants of the Annalise CXR Edge products will be offered in Australia.